1-3 of 3
Ute I. Schwarz
Close
Sort by
Journal Articles

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy

Clinical Trials & Observations
Inna Y. Gong, Rommel G. Tirona, Ute I. Schwarz, Natalie Crown, George K. Dresser, Samantha LaRue, Nicole Langlois, Alejandro Lazo-Langner, Guangyong Zou, Dan M. Roden, C. Michael Stein, Marc Rodger, Marc Carrier, Melissa Forgie, Philip S. Wells, Richard B. Kim
Journal: Blood
Blood (2011) 118 (11): 3163–3171.
https://doi.org/10.1182/blood-2011-03-345173
Published: 2011
Includes: Supplemental data
Journal Articles

Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy

Clinical Trials & Observations
Chun Li, Ute I. Schwarz, Marylyn D. Ritchie, Dan M. Roden, C. Michael Stein, Daniel Kurnik
Journal: Blood
Blood (2009) 113 (17): 3925–3930.
https://doi.org/10.1182/blood-2008-09-176859
Published: 2009
Journal Articles

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

Clinical Trials & Observations
Gregory M. Cooper, Julie A. Johnson, Taimour Y. Langaee, Hua Feng, Ian B. Stanaway, Ute I. Schwarz, Marylyn D. Ritchie, C. Michael Stein, Dan M. Roden, Joshua D. Smith, David L. Veenstra, Allan E. Rettie, Mark J. Rieder
Journal: Blood
Blood (2008) 112 (4): 1022–1027.
https://doi.org/10.1182/blood-2008-01-134247
Published: 2008
Includes: Supplemental data